// App-Quantinova.ai

P600 : Ustekinumab for Crohn’s disease: a nationwide real-life observational cohort study from Finland

Researchers

Presenter

  • A Eberl

Principal Investigators

  • C-G af Bjrkesten

  • M Heikkinen

  • E Hirsi

  • M Kellokumpu

  • I Koskinen

  • V Moilanen

  • C Nielsen

  • H Nuutinen

  • U-M Suhonen

  • K Utriainen

  • I Vihril

  • E Soini

  • C Wennerstrm

  • R Nissinen

  • A Borsi

  • M Koivunen

  • J Tillonen

  • T Sipponen

Medical Centers

  • Helsinki University Central Hospital, Division of Gastroenterology, Helsinki, Finland

  • Esior Oy, Kuopio, Finland

  • Helsinki University Hospital/Jorvi Hospital, Department of Gastroenterology, Espoo, Finland

  • Kuopio University Hospital, Department of Pediatrics, Kuopio, Finland

  • South Karelia Central Hospital, Department of Medicine, Lappeenranta, Finland

  • Satakunta Central Hospital, Department of Internal Medicine, Pori, Finland

  • Central Hospital of Central Finland, Department of Internal Medicine, Jyväskylä, Finland

  • Satakunta Central Hospital, Department of Internal Medicine, Pori, Finland

  • Satakunta Central Hospital, Department of Internal Medicine, Pori, Finland

  • Turku University Hospital, Division of Gastroenterology, Department of Medicine, Turku, Finland

  • Satakunta Central Hospital, Department of Internal Medicine, Pori, Finland

  • Turku University Hospital, Division of Gastroenterology, Department of Medicine, Turku, Finland

  • Central Ostrobothnia Central Hospital, Department of Internal Medicine, Kokkola, Finland

  • Janssen-Cilag AB, Medical Affairs, Solna, Sweden

  • Janssen-Cilag Oy, Medical Affairs, Espoo, Finland

  • Janssen-Cilag Limited, EPC - HEMAR, Buckinghamshire, UK

  • Department of Pediatrics, Paijat-Hame Central Hospital, Lahti, Finland

Locations

  • Finland

  • Sweden

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

Biomarkers

  • N/A

Drug/Treatment

  • Ustekinumab

Outcome

  • N/A

Study Design

  • Observational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved